CHICAGO (Reuters) - Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that ...

New moles, changes in existing moles, or spots that bleed and don't heal can be signs of skin cancer. Women, especially those ...

A new mouse study by researchers at the University of California (UC), San Diego, School of Medicine reveals that an enzyme ...

Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by ...

“The survival rate for pancreatic cancer is only 13% ... that found women of African descent are more likely to be diagnosed with later stages of cancer than women of other ethnic backgrounds. Reasons ...

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study.

Scientists have analyzed thousands of mutations in the BRCA2 cancer gene, offering crucial insights. This research could help mitigate patient concerns or guide tailored treatments. By utilizing ...

Pancreatic ductal adenocarcinoma remains a challenge to treat due to its complex biology and resistance mechanisms.

Breast reconstruction is a common procedure for women who have undergone mastectomy as part of their breast cancer treatment.